Dimcho R. Bachvarov
9 Rue McMahon
Quebec, QC, Canada
Quebec, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Lymph node involvement, surgery and adjuvant treatment in primary Endometrioid Ovarian carcinoma PAtients with eaRly-stage Disease (LEOPARD) - a multinational team initiative.
Journal: Gynecologic oncology
Published: February 01, 2026
Correction: Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells.
Journal: PloS one
Published: November 03, 2025
Pre-operative levels of angiopoietin protein-like 3 (ANGPTL3) in women diagnosed with high-grade serous carcinoma of the ovary.
Journal: Lipids in health and disease
Published: October 09, 2023
LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model.
Journal: International journal of molecular sciences
Published: June 08, 2020
Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapy.
Journal: Journal of translational medicine
Published: May 30, 2020
LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway.
Journal: International journal of molecular sciences
Published: January 29, 2020
The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression.
Journal: International journal of molecular sciences
Published: April 18, 2019
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer.
Journal: PloS one
Published: January 25, 2019
Proteases and their inhibitors as prognostic factors for high-grade serous ovarian cancer.
Journal: Pathology, research and practice
Published: November 22, 2018
Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers.
Journal: BMC cancer
Published: October 06, 2017
Altered expression of different GalNAc‑transferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer.
Journal: International journal of oncology
Published: June 27, 2017
Last Updated: 09/26/2026